Health insurer Anthem profit beats, raises 2019 earnings forecast

This post was originally published on this site

https://i-invdn-com.akamaized.net/trkd-images/LYNXMPEF9M0S9_L.jpg

(Reuters) – Anthem Inc (N:) reported a better-than-expected quarterly profit on Wednesday as it benefited from higher sales of its government-backed health plans, prompting the health insurer to raise its full-year profit forecast.

The company, which earlier this year launched pharmacy benefits business IngenioRx, forecast adjusted 2019 earnings of more than $19.40 per share, up from its prior view of more than$19.30.

Operating revenue from its government business, which sells Medicare and Medicaid health plans, rose 14% to $15.96 billion.

The company said its benefit expense ratio — the percentage of premiums paid for medical services — worsened to 87.2% from 84.8% a year earlier. Analysts on average expected 86.59%, according to IBES data from Refinitiv. A lower benefit expense ratio is better for health insurers.

Net income rose to $1.18 billion, or $4.55 per share, in the third quarter ended Sept. 30 from $960 million, or $3.62 per share, a year earlier.

Excluding items, the company earned $4.87 per share, ahead of the average analyst estimate of $4.82 per share.

Total operating revenue rose 15% to $26.44 billion, beating estimates of $25.88 billion.

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.